Spiceland CM, Lodhia N. Endoscopy in inflammatory bowel disease: Role in diagnosis, management, and treatment. World J Gastroenterol 2018; 24(35): 4014-4020 [PMID: 30254405 DOI: 10.3748/wjg.v24.i35.4014]
Corresponding Author of This Article
Nilesh Lodhia, MD, Associate Professor, Division of Gastroenterology and Hepatology, University of North Carolina, Charlotte, CHS Digestive Health 1025 Morehead Medical Drive, Suite 300 Charlotte, NC 28204,United States. Nilesh.lodhia@atriumhealth.org
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 3 Surveillance for Colorectal Endoscopic Neoplasia Detection and Management in Inflammatory Bowel Disease Patients: International Consensus recommendations for optimizing detection and management of dysplasia in inflammatory bowel disease[28]
Detection of dysplasia on surveillance colonoscopy
When performing surveillance with white-light colonoscopy, high definition is recommended rather than standard definition
When performing surveillance with standard-definition colonoscopy, chromoendoscopy is recommended rather than white-light colonoscopy
When performing surveillance with high-definition colonoscopy, chromoendoscopy is suggested rather than white-light colonoscopy
When performing surveillance with standard-definition colonoscopy, narrow-band imaging is not suggested in place of white-light colonoscopy
When performing surveillance with high-definition colonoscopy, narrow-band imaging is not suggested in place of white-light colonoscopy
When performing surveillance with image-enhanced high-definition colonoscopy, narrow-band imaging is not suggested in place of chromoendoscopy
Management of dysplasia discovered on surveillance colonoscopy
After complete removal of endoscopically resectable polypoid dysplastic lesions, surveillance colonoscopy is recommended rather than colectomy
After complete removal of endoscopically resectable nonpolypoid dysplastic lesions, surveillance colonoscopy is suggested rather than colectomy
For patients with endoscopically invisible dysplasia (confirmed by a GI pathologist) referral is suggested to an endoscopist with expertise in IBD surveillance using chromoendoscopy with high-definition colonoscopy
Table 4 Rutgeerts score for Crohn’s disease recurrence at ileocolonic anastomoses[35]
i0 no lesions in neoterminal ileum
i1 < 5 aphthous lesions in neoterminal ileum
i2 > 5 aphthous lesions with normal mucosa, skip areas with larger lesions, anastomotic lesions
i3 diffuse aphthous ileitis
i4 diffuse inflammation with ulcer, nodules, and/or stenosis
Citation: Spiceland CM, Lodhia N. Endoscopy in inflammatory bowel disease: Role in diagnosis, management, and treatment. World J Gastroenterol 2018; 24(35): 4014-4020